We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hill-Rom Holdings Acquires Welch Allyn

By HospiMedica International staff writers
Posted on 29 Jun 2015
Hill-Rom Holdings (Batesville, IN, USA), a leading provider of technologies and services to the healthcare industry, has agreed to purchase Welch Allyn (Skaneateles Falls, NY, USA) in a bid to expand into the point-of-care diagnostics market.

The mutual infrastructure-leveraging move, part of a larger merger process that is transforming the healthcare technology industry, will allow for improved offerings in areas such as diagnostics, sensing and patient-monitoring technologies, clinical workflow, surgical safety and efficiency, respiratory health, wound care and prevention, and mobility technology. More...
The integrated company will thus hold positions across the total care continuum, including primary and intensive care units (ICUs), patient rooms, operating rooms (ORs), and post-acute care wards.

The combined entity will also expand its channel access and call points, as well as enhance clinical workflow through electronic medical record (EMR) connectivity solutions. In a joint statement, the companies said that combining Hill-Rom’s leading position in hospitals and ORs worldwide with Welch Allyn’s leading position in point of care diagnostics and testing would expand their ability to help healthcare providers focus on patient care solutions, and provide a wide range of innovative solutions to a global patient-centric, customer base focused on quality and efficiency.

“As one company, we will have the infrastructure, capabilities and innovative product portfolio to faster pursue a differentiated business model that meets the evolving needs of patients and customers and delivers superior healthcare outcomes across multiple care settings,” said John Greisch, president and CEO of Hill-Rom. “We look forward to welcoming the Welch Allyn team to Hill-Rom and combining our two great companies to continue our shared mission of improving patient outcomes and reducing patient costs.”

“This transaction represents a compelling opportunity for Welch Allyn with the right partner in Hill-Rom, who appreciates our company's special history, strengths, and strategy,” said Steve Meyer, president and CEO of Welch Allyn. “Hill-Rom and Welch Allyn share a commitment to patients and a history of delivering innovative solutions. Hill-Rom has the scale, geographic reach, experience and vision necessary to foster the next stage of growth and to ensure Welch Allyn's continued success.”

The acquisition was made for approximately USD 2.05 billion in cash and stock. Under the terms of the agreement, Welch Allyn shareholders will receive USD 1.625 billion in cash and approximately 8.1 million newly-issued shares of Hill-Rom common stock.

Related Links:

Hill-Rom Holdings
Welch Allyn



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.